免疫分子及相關(guān)免疫細(xì)胞在肝衰竭中的作用機(jī)制

打開文本圖片集

基金項(xiàng)目：國家自然科學(xué)基金委區(qū)域聯(lián)合基金項(xiàng)目（U23A20521）；姚春桂派中醫(yī)大師傳承工作室（GZY2024002）；廣西疑難重癥中醫(yī)診療研究團(tuán)隊(duì)（2022A001）；廣西科技重大專項(xiàng)（桂科AA23023035）；優(yōu)勢病種肝衰竭-中藥保留灌腸技術(shù)治療肝衰竭/肝性腦病的規(guī)范化研究（2023019-03）

Abstract：Liverfailure（LF）isasevere clinicalsyndromecharacterizedbysevereimpairmentordecompensationofliverfunction. Atpresent，thekeyroleofimmune moleculesinthepathogenesisofLFhasbeenwellestablished.These molecules notonlydirectly participate inthepathologicalprocessofLF，butalsoinfluencethecourseofLFbymodulating thebehaviorofimmunecels.In addition，immune moleculescanbeusedaspotentialbiomarkersforevaluatingtheprognosisofLF.Thisarticlesummarizes therole of immune moleculesinLFand explores thetherapeutic strategies basedonthese immune molecules，inorder to providenew directions for the diagnosis and treatment of LF.

Keywords：Immune molecules；Liver Failure；Therapeutics

Researchfunding：RegionalJointFund Projectof National Natural Science Foundationof China（U23A2o521）；Yao ChunGui Schoolof Traditional Chinese Medicine Masters Inheritance Workshop（GZY2024002）；Guangxi Traditional Chinese Medicine DiagnosisandTreatmentof Diffcultand Serious Diseases Research Team（2O22Ao1）；Guangxi Major Special Projectof Science andTechnology（GuiKeAA23O23035）；Advantageous Disease LiverFailure-Traditional Chinese MedicineRetentionandEnema Technique for the Treatment of Liver Failure/Hepatic Encephalopathy Standardised Research （2O23019-03）

肝衰竭是一種嚴(yán)重的臨床綜合征，表現(xiàn)為肝臟合成、解毒、排泄和生物轉(zhuǎn)化等關(guān)鍵功能的嚴(yán)重障礙或失代償。（剩余18434字）